Home/Filings/4/0001209191-16-148720
4//SEC Filing

ALBIREO PHARMA, INC. 4

Accession 0001209191-16-148720

CIK 0001322505operating

Filed

Nov 6, 7:00 PM ET

Accepted

Nov 7, 6:40 PM ET

Size

5.6 KB

Accession

0001209191-16-148720

Insider Transaction Report

Form 4
Period: 2016-11-03
Soni Paresh
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2016-11-03+81,83181,831 total
    Exercise: $19.47Exp: 2026-11-02Common Stock (81,831 underlying)
Footnotes (1)
  • [F1]This option vests and becomes exercisable as to 25% of the underlying shares on September 6, 2017 and the remainder in equal installments on the last day of the 12 consecutive calendar quarters beginning with December 31, 2017 and ending on September 30, 2020.

Issuer

ALBIREO PHARMA, INC.

CIK 0001322505

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001322505

Filing Metadata

Form type
4
Filed
Nov 6, 7:00 PM ET
Accepted
Nov 7, 6:40 PM ET
Size
5.6 KB